KPV Peptide Research Overview
KPV is a tripeptide (Lys-Pro-Val) derived from alpha-melanocyte-stimulating hormone (alpha-MSH). It consists of the C-terminal amino acid sequence of alpha-MSH and has been the subject of research investigating its anti-inflammatory and immunomodulatory properties.
Mechanism of Action
KPV research has focused on its interaction with melanocortin receptors and downstream signaling pathways. Studies have examined its effects on NF-kB signaling, a key regulator of inflammatory gene expression. In vitro and animal model research has investigated KPV in the context of intestinal inflammation, wound healing, and immune cell modulation.
Research Applications
Published research on KPV has explored its potential in models of inflammatory bowel conditions, skin inflammation, and antimicrobial activity. The peptide has been studied in both cell culture and animal models across multiple research institutions.
For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.
Want more research like this?
Weekly peptide study breakdowns. No spam. Unsubscribe anytime.
Maple 

Reviews
There are no reviews yet.